Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7699)
All Articles published online
|
Publishing Process of This Article
|
Dec 16, 2021 (publication date) through Nov 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li RJ, Dai YY, Qin C, Huang GR, Qin YC, Huang YY, Huang ZS, Luo XK, Huang YQ. Application of traditional Chinese medicine in treatment of Helicobacter pylori infection. World J Clin Cases 2021; 9(35): 10781-10791 [PMID: 35047590 DOI: 10.12998/wjcc.v9.i35.10781] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v9/i35/10781.htm |
| Number | Citing Articles |
| 1 |
Zheyu Sun, Haiyan Deng, Yuna Liu, Jing Zhang, Chunfeng Xu. A Systematic Review and Meta-Analysis of Xiangsha Liujunzi Decoction in
the Treatment of Chronic Gastritis. Combinatorial Chemistry & High Throughput Screening 2024; 27(3): 386 doi: 10.2174/0113862073252121230925103843
|
| 2 |
Yong Zhi, Shanshan Xie, Changming Shao, Binfang Zeng, Mohammad Farukh Hashmi. A Web‐Based Pharmacological Approach to the Mechanism of Action of Rhizoma Phragmitis and Rhizoma Curcumae in the Treatment of Chronic Atrophic Gastritis. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/3483774
|
| 3 |
Zhang Yu, Wu-Dong Sheng, Xu Yin, Yu Bin. <i>Coptis</i>, <i>Pinellia</i>, and <i>Scutellaria </i>as a promising new drug combination for treatment of <i>Helicobacter pylori </i>infection . World Journal of Clinical Cases 2022; 10(34): 12500-12514 doi: 10.12998/wjcc.v10.i34.12500
|
| 4 |
Yanyan Shi, Jing Ning, Kelsang Norbu, Xingzi Hou, Huiling Zheng, Hejun Zhang, Wei Yu, Feng Zhou, Yuan Li, Shigang Ding, Qingying Zhang. The tibetan medicine Zuozhu-Daxi can prevent Helicobacter pylori induced-gastric mucosa inflammation by inhibiting lipid metabolism. Chinese Medicine 2022; 17(1) doi: 10.1186/s13020-022-00682-9
|
| 5 |
Zhenyu Jiang, Boning Deng, Yaqi Zhang, Ye Li, Zhijun Yu, Haiying Deng, Yajun Chen. Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy forHelicobacter pylori-positive peptic ulcers: a systematic review and network meta-analysis. BMJ Open 2024; 14(4): e074188 doi: 10.1136/bmjopen-2023-074188
|
| 6 |
Zeeshan Umar, Jia-Wei Tang, Barry J. Marshall, Alfred Chin Yen Tay, Liang Wang.
Rapid diagnosis and precision treatment of
Helicobacter pylori
infection in clinical settings
. Critical Reviews in Microbiology 2024; : 1 doi: 10.1080/1040841X.2024.2364194
|
| 7 |
Xiao-Hua Li, Jia-Yin Xu, Xue Wang, Li-Juan Liao, Liang Huang, Yan-Qiang Huang, Zeng-Feng Zhang. BanXiaXieXin decoction treating gastritis mice with drug-resistant <i>Helicobacter pylori</i> and its mechanism. World Journal of Gastroenterology 2023; 29(18): 2818-2835 doi: 10.3748/wjg.v29.i18.2818
|
| 8 |
Ling Ou, Zhixiang Zhu, Yajie Hao, Qingwei Li, Hengrui Liu, Qingchang Chen, Chang Peng, Chuqiu Zhang, Yuanjing Zou, Junwei Jia, Hui Li, Yanhua Wang, Bingmei Su, Yuqian Lai, Meiyun Chen, Haobo Chen, Zhong Feng, Guimin Zhang, Meicun Yao. 1,3,6-Trigalloylglucose: A Novel Potent Anti-Helicobacter pylori Adhesion Agent Derived from Aqueous Extracts of Terminalia chebula Retz. Molecules 2024; 29(5): 1161 doi: 10.3390/molecules29051161
|
| 9 |
Ling Ou, Heng-rui Liu, Xiao-yan Shi, Chang Peng, Yuan-jing Zou, Jun-wei Jia, Hui Li, Zhi-xiang Zhu, Yan-hua Wang, Bing-mei Su, Yu-qian Lai, Mei-yun Chen, Wei-xing Zhu, Zhong Feng, Gui-min Zhang, Mei-cun Yao. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. Journal of Ethnopharmacology 2024; 320: 117428 doi: 10.1016/j.jep.2023.117428
|
| 10 |
Jin Song, Xiaolong Xu, Shasha He, Huicun Zhang, Ning Wang, Yunjing Bai, Bo Li, Shengsheng Zhang. Identification of the therapeutic effect and molecular mechanism of Coptis chinensis Franch. and Magnolia officinalis var. biloba on chronic gastritis. Journal of Ethnopharmacology 2023; 317: 116864 doi: 10.1016/j.jep.2023.116864
|
| 11 |
Yu‐Zhen Wang, Jie Chen, Shi‐Qin Pei, Chen Wang, Gang Han, Lian‐Di Kan, Liu‐Cheng Li. Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection. Drug Development Research 2023; 84(2): 326 doi: 10.1002/ddr.22025
|
| 12 |
Zhaoyang Li, Xueming He, Chuming Liu. Shaoyao Gancao Decoction Mitigates Helicobacter Pylori-Induced Chronic Atrophic Gastritis by Suppressing MAOB. The Tohoku Journal of Experimental Medicine 2024; 263(4): 217 doi: 10.1620/tjem.2024.J038
|
| 13 |
Qian Luo, Na Liu, Sugui Pu, Ze Zhuang, Hang Gong, Dekui Zhang. A review on the research progress on non-pharmacological therapy of Helicobacter pylori. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1134254
|
| 14 |
Xue-feng Shi, Qi Yu, Kai-bo Wang, Yi-dong Fu, Shun Zhang, Zhen-yun Liao, Yan Li, Ting Cai. Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-39627-z
|
| 15 |
Qian Zhao, Wen-jia Wang, Shui-ping Zhou, Jing Su, He Sun, Jing-bo Zhai, Yun-hui Hu. Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.959184
|